155. ランドウ・クレフナー症候群
[臨床試験数:1,薬物数:2(DrugBank:2),標的遺伝子数:29,標的パスウェイ数:14]
Searched query = "Acquired aphasia with convulsive disorder", "Landau-Kleffner syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02904265 (ClinicalTrials.gov) | September 2016 | 13/9/2016 | Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome | Non-inferiority Prospective Randomized Trial of Acetazolamide Versus Diazepam in Patients With Continuous Spike and Wave in Sleep (CSWS)/Landau Kleffner Syndrome (LKS) | Landau-Kleffner Syndrome;Status Epilepticus, Electrographic | Drug: Diazepam;Drug: Acetazolamide | Mayo Clinic | NULL | Terminated | 3 Years | 12 Years | All | 3 | Phase 2;Phase 3 | United States |